Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Cash & Current Investments (2022 - 2025)

Historic Cash & Current Investments for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $7.7 million.

  • bioAffinity Technologies' Cash & Current Investments rose 86250.0% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 86250.0%. This contributed to the annual value of $1.1 million for FY2024, which is 6082.71% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Cash & Current Investments is $7.7 million, which was up 86250.0% from $802835.0 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Cash & Current Investments ranged from a high of $13.5 million in Q3 2022 and a low of $444706.0 during Q1 2025
  • Moreover, its 4-year median value for Cash & Current Investments was $2.8 million (2023), whereas its average is $5.0 million.
  • Per our database at Business Quant, bioAffinity Technologies' Cash & Current Investments plummeted by 9034.57% in 2024 and then soared by 86250.0% in 2025.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Cash & Current Investments stood at $11.4 million in 2022, then crashed by 75.28% to $2.8 million in 2023, then tumbled by 60.83% to $1.1 million in 2024, then surged by 596.65% to $7.7 million in 2025.
  • Its Cash & Current Investments stands at $7.7 million for Q3 2025, versus $802835.0 for Q2 2025 and $444706.0 for Q1 2025.